Literature DB >> 25867280

Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE Registry.

Jonathan C Hsu1, Paul S Chan2, Fengming Tang3, Thomas M Maddox4, Gregory M Marcus5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25867280      PMCID： PMC4540345          DOI： 10.1001/jamainternmed.2015.0920

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  28 in total

Review 1.  Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies.

Authors:  Sander Greenland
Journal:  Am J Epidemiol       Date:  2004-08-15       Impact factor: 4.897

2.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Authors:  A S Go; E M Hylek; L H Borowsky; K A Phillips; J V Selby; D E Singer
Journal:  Ann Intern Med       Date:  1999-12-21       Impact factor: 25.391

5.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

6.  Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

Authors:  Carl van Walraven; Robert G Hart; Daniel E Singer; Andreas Laupacis; Stuart Connolly; Palle Petersen; Peter J Koudstaal; Yuchiao Chang; Beppie Hellemons
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

8.  The natural history of lone atrial fibrillation. A population-based study over three decades.

Authors:  S L Kopecky; B J Gersh; M D McGoon; J P Whisnant; D R Holmes; D M Ilstrup; R L Frye
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

9.  Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Thomas J Wang; Eric P Leip; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Ralph B D'Agostino; Joseph M Massaro; Alexa Beiser; Philip A Wolf; Emelia J Benjamin
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

10.  A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.

Authors:  Thomas J Wang; Joseph M Massaro; Daniel Levy; Ramachandran S Vasan; Philip A Wolf; Ralph B D'Agostino; Martin G Larson; William B Kannel; Emelia J Benjamin
Journal:  JAMA       Date:  2003-08-27       Impact factor: 56.272
View more
  8 in total

Review 1.  Role of the anticoagulant monitoring service in 2018: beyond warfarin.

Authors:  Nathan P Clark
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  2016 Update on Medical Overuse: A Systematic Review.

Authors:  Daniel J Morgan; Sanket S Dhruva; Scott M Wright; Deborah Korenstein
Journal:  JAMA Intern Med       Date:  2016-11-01       Impact factor: 21.873

3.  Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge.

Authors:  Bory Kea; Bethany T Waites; Amber Lin; Merritt Raitt; David R Vinson; Niroj Ari; Luke Welle; Andrew Sill; Dana Button; Benjamin C Sun
Journal:  West J Emerg Med       Date:  2020-06-29

Review 4.  Choosing Wisely Campaign - Innovations in Cardiovascular Science and The United States Healthcare System.

Authors:  Hiba Rehman; Fahad Ali; Muhammad Asif Mangi
Journal:  Cureus       Date:  2018-07-05

5.  Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence.

Authors:  Eyob Alemayehu Gebreyohannes; Sandra Salter; Leanne Chalmers; Luke Bereznicki; Kenneth Lee
Journal:  Am J Cardiovasc Drugs       Date:  2020-12-28       Impact factor: 3.571

6.  Use of Direct Oral Anticoagulants in Canadian Primary Care Practice 2010-2015: A Cohort Study From the Canadian Primary Care Sentinel Surveillance Network.

Authors:  Finlay A McAlister; Scott Garrison; Leanne Kosowan; Justin A Ezekowitz; Alexander Singer
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501

7.  SUPPORT-AF: Piloting a Multi-Faceted, Electronic Medical Record-Based Intervention to Improve Prescription of Anticoagulation.

Authors:  Alok Kapoor; Azraa Amroze; Jessica Golden; Sybil Crawford; Kevin O'Day; Rasha Elhag; Ahmed Nagy; Steve A Lubitz; Jane S Saczynski; Jomol Mathew; David D McManus
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

8.  Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.

Authors:  Christopher T Sciria; Thomas M Maddox; Lucas Marzec; Benjamin Rodwin; Salim S Virani; Amarnath Annapureddy; James V Freeman; Ali O'Hare; Yuyin Liu; Yang Song; Gheorghe Doros; Yue Zheng; Jane J Lee; Ramesh Daggubati; Lina Vadlamani; Christopher Cannon; Nihar R Desai
Journal:  Clin Cardiol       Date:  2020-05-06       Impact factor: 3.287
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.